Novo Nordisk's hemophilia A drug Mim8 shows success in pediatric trial, Mim8 could compete with Roche's Hemlibra, with plans for regulatory filing this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback